[Protective action of Trasylol in experimental kidney disorders].
D000469:Alkaline Phosphatase / Q000032:analysis; D000618:Aminohippuric Acids; D000818:Animals; D007611:Aprotinin / Q000494:pharmacology*; D001219:Aspartate Aminotransferases / Q000032:analysis; D002056:Burns / Q000150:complications; D005634:Fructose-Bisphosphate Aldolase / Q000032:analysis; D006019:Glycolysis; D007511:Ischemia; D007668:Kidney / Q000187:drug effects* / Q000201:enzymology; D007674:Kidney Diseases / Q000517:prevention & control; D007684:Kidney Tubules; D007770:L-Lactate Dehydrogenase / Q000032:analysis; D008297:Male; D010101:Oxygen Consumption; D051381:Rats; D012078:Renal Artery Obstruction / Q000150:complications; D012771:Shock, Hemorrhagic / Q000150:complications
D000618:Aminohippuric Acids; D007611:Aprotinin; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D005634:Fructose-Bisphosphate Aldolase
Schutzeffekt des Trasylol bei experimentellen Nierenschäden.